98%
400G
Door-to-door
| Appearance | - | UN | - |
| HS | - | DG Class | - |
| Synonyms | Paxlovid; (1R,2S,5S)-N-[(1S)-1-Cyano-2-[(3S)-2-Oxopyrrolidin-3-yl]Ethyl]-3-[(2S)-3,3-Dimethyl-2-[(2,2,2-Trifluoroacetyl)Amino]Butanoyl]-6,6-Dimethyl-3-Azabicyclo[3.1.0]Hexane-2-Carboxamide; (1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-Oxopyrrolidin-3-yl)Ethyl)-6,6-Dimethyl-3-(3-Methyl-N-(Trifluoroacetyl)-L-Valyl)-3-Azabicyclo(3.1.0)Hexane-2-Carboxamide; (1R,2S,5S)-N-[(1S)-1-Cyano-2-[(3S)-2-Oxopyrrolidin-3-yl]Ethyl]-3-[(2S)-3,3-Dimethyl-2-(2,2,2-Trifluoroacetamido)Butanoyl]-6,6-Dimethyl-3-Azabicyclo[3.1.0]Hexane-2-Carboxamide; (1R,2S,5S)-N-((S)-1-Cyano-2-((S)-2-Oxopyrrolidin-3-yl)Ethyl)-3-((S)-3,3-Dimethyl-2-(2,2,2-Trifluoroacetamido)Butanoyl)-6,6-Dimethyl-3-Azabicyclo[3.1.0]Hexane-2-Carboxamide; 3-Azabicyclo(3.1.0)Hexane-2-Carboxamide, N-((1S)-1-Cyano-2-((3S)-2-oxo-3-Pyrrolidinyl)Ethyl)-3-((2S)-3,3-Dimethyl-1-oxo-2-((2,2,2-Trifluoroacetyl)Amino)Butyl)-6,6-Dimethyl-, (1R,2S,5S)-; 3-Azabicyclo[3.1.0]Hexane-2-Carboxamide, N-[(1S)-1-Cyano-2-[(3S)-2-oxo-3-Pyrrolidinyl]Ethyl]-3-[(2S)-3,3-Dimethyl-1-oxo-2-[(2,2,2-Trifluoroacetyl)Amino]Butyl]-6,6-Dimethyl-, (1R,2S,5S)-; (1S,3aS,4aR)-N-[(1S)-1-Cyano-2-[(3S)-2-Oxotetrahydro-1H-Pyrrol-3-yl]Ethyl]-2-[(2S)-3,3-Dimethyl-1-oxo-2-[(Trifluoroacetyl)Amino]Butyl]-4,4-Dimethyl-2,3,3a,4a-Tetrahydro-1H-Cyclopropa[1,2-c]Pyrrole-1-Carboxamide | ||